BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8537378)

  • 1. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein.
    Blencowe C; Hermetter A; Kostner GM; Deigner HP
    J Biol Chem; 1995 Dec; 270(52):31151-7. PubMed ID: 8537378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
    Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
    J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C; Lesnik P; Chapman MJ; Ninio E
    Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.
    MacPhee CH; Moores KE; Boyd HF; Dhanak D; Ife RJ; Leach CA; Leake DS; Milliner KJ; Patterson RA; Suckling KE; Tew DG; Hickey DM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):479-87. PubMed ID: 10024526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease.
    Tsironis LD; Katsouras CS; Lourida ES; Mitsios JV; Goudevenos J; Elisaf M; Tselepis AD
    Atherosclerosis; 2004 Nov; 177(1):193-201. PubMed ID: 15488884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
    Satoh K; Imaizumi T; Yoshida H; Takamatsu S
    J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP; Pritchard PH
    J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
    Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
    Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
    Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
    Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
    J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
    Ostermann G; Kostner GM; Gries A; Malle E; Till U
    Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of phospholipase A-resistant pyrene-dialkyl-glycerophosphocholine to plasma lipoproteins: differences between Lp[a] and LDL.
    Gorges R; Hofer G; Sommer A; Stütz H; Grillhofer H; Kostner GM; Paltauf F; Hermetter A
    J Lipid Res; 1995 Feb; 36(2):251-9. PubMed ID: 7751812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.